Back
Kymera Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
KYMR
Kymera Therapeutics
Last Price:
$46.20
Seasonality Move:
-8.02%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.
Kymera Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.34 | Buy |
20-day SMA: | 45.15 | Buy |
50-day SMA: | 40.38 | Buy |
200-day SMA: | 39.4 | Buy |
8-day EMA: | 40.8 | Buy |
20-day EMA: | 26.9 | Buy |
50-day EMA: | 13.67 | Buy |
200-day EMA: | 3.89 | Buy |
Kymera Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 12.69 | Buy |
Relative Strength Index (14 RSI): | 61.48 | Buy |
Chaikin Money Flow: | -362590 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.35 - 46.59) | Buy |
Bollinger Bands (100): | (27.41 - 43.25) | Buy |
Kymera Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Kymera Therapeutics Stock
Is Kymera Therapeutics Stock a Buy?
-
Kymera Therapeutics share price is 46.18 while KYMR 8-day simple moving average is 45.34, which is a Buy signal.
-
The stock price of KYMR is 46.18 while Kymera Therapeutics 20-day SMA is 45.15, which makes it a Buy.
-
Kymera Therapeutics 50-day simple moving average is 40.38 while KYMR share price is 46.18, making it a Buy technically.
-
KYMR stock price is 46.18 and Kymera Therapeutics 200-day simple moving average is 39.40, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
60
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy or a Sell?
-
Kymera Therapeutics stock is rated a BuyThe current Kymera Therapeutics [KYMR] share price is $46.18. The Score for KYMR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics Stock Info
Market Cap:
3B
Price in USD:
46.18
Share Volume:
501.5K
Kymera Therapeutics 52-Week Range
52-Week High:
53.27
52-Week Low:
19.45
Buy
60
Kymera Therapeutics (KYMR)
is a Buy
Kymera Therapeutics Share Price Forecast
-
What is the Kymera Therapeutics stock price today?The Kymera Therapeutics stock price is 46.18 USD today.
-
Will KYMR stock go up or go down?Kymera Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Kymera Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics is not overvalued.
Is Kymera Therapeutics Stock a Buy?
-
Kymera Therapeutics share price is 46.18 while KYMR 8-day exponential moving average is 40.80, which is a Buy signal.
-
The stock price of KYMR is 46.18 while Kymera Therapeutics 20-day EMA is 26.90, which makes it a Buy.
-
Kymera Therapeutics 50-day exponential moving average is 13.67 while KYMR share price is 46.18, making it a Buy technically.
-
KYMR stock price is 46.18 and Kymera Therapeutics 200-day simple moving average is 3.89, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics
Is Kymera Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.65 per share, and a decrease next year of $0.51 per share.
Technical Analysis of Kymera Therapeutics
Should I short Kymera Therapeutics stock?
-
KYMR Moving Average Covergence Divergence (MACD) indicator is 12.69, suggesting Kymera Therapeutics is a Buy
-
Kymera Therapeutics Relative Strength Index (RSI) is 61.48, which suggest Kymera Therapeutics is overbought
-
The Bollinger Bands (25) for Kymera Therapeutics is (44.35 - 46.59), which suggest Kymera Therapeutics is a Buy
-
The Bollinger Bands (100) for Kymera Therapeutics is (27.41 - 43.25), which suggest Kymera Therapeutics is a Buy
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.